Impel NeuroPharma, a Seattle biotech co-founded by Professor Rodney Ho and John Hoekman, Ph.D., ’10, has received a $750,000 research grant from the Department of Defense’s Chemical and Biological Defense Program. The project will assess how therapeutic drugs might break the blood-brain barrier to treat people exposed to chemical warfare agents. Read more.